IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2
- PMID: 8892656
IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2
Abstract
IL-2 administration in vivo has been shown to increase CD4+ T cell counts in HIV+ patients. We have previously reported that PBMC from HIV-infected patients undergo marked spontaneous apoptosis in vitro. In this study, we examined the effect of IL-2 added in vitro upon culture-induced apoptosis in PBMC from 80 HIV-infected patients by flow cytometry. IL-2 at concentrations of > or = 10 U/ml significantly reduced spontaneous apoptosis in CD3+ T lymphocytes in patients but not in healthy volunteers. Interestingly, we observed that Bcl-2 expression in patient lymphocytes decreased rapidly upon in vitro culture while that in cells of healthy volunteers was relatively unaffected. The most significant decrease in Bcl-2 expression was noted in the apoptotic cell population. The IL-2-mediated reduction in lymphocyte apoptosis was found to be associated with the blocking of this culture-induced down-modulation of Bcl-2 expression. IL-2 did not induce significant expansion of lymphocytes during the culture period nor did it affect Fas Ag expression in patient cells, which were already expressing Fas maximally. These findings strongly suggest that IL-2 mediates its apoptosis-blocking effects via suppressing down-modulation of Bcl-2. Our findings also provide an experimental basis for the ongoing therapies utilizing this cytokine for slowing HIV disease progression.
Similar articles
-
Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.J Immunol. 1996 Mar 15;156(6):2282-93. J Immunol. 1996. PMID: 8690919
-
Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression.Cell Death Differ. 1999 Oct;6(10):1002-11. doi: 10.1038/sj.cdd.4400575. Cell Death Differ. 1999. PMID: 10556978
-
Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype.J Immunol. 1997 Mar 15;158(6):2964-76. J Immunol. 1997. PMID: 9058836
-
Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.J Immunol. 1998 Apr 1;160(7):3194-206. J Immunol. 1998. PMID: 9531275
-
Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.J Immunol. 1998 Feb 15;160(4):1627-37. J Immunol. 1998. PMID: 9469419
Cited by
-
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals.Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2355-60. doi: 10.1073/pnas.0610775104. Epub 2007 Feb 6. Proc Natl Acad Sci U S A. 2007. PMID: 17284597 Free PMC article.
-
Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.J Virol. 2001 Nov;75(22):10843-55. doi: 10.1128/JVI.75.22.10843-10855.2001. J Virol. 2001. PMID: 11602725 Free PMC article.
-
Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection.Immunol Res. 2007;38(1-3):373-86. doi: 10.1007/s12026-007-0036-9. Immunol Res. 2007. PMID: 17917047
-
Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease.J Virol. 2001 Oct;75(20):9983-5. doi: 10.1128/JVI.75.20.9983-9985.2001. J Virol. 2001. PMID: 11559831 Free PMC article.
-
Low cholesterol? Don't brag yet ... hypocholesterolemia blunts HAART effectiveness: a longitudinal study.J Int AIDS Soc. 2010 Jul 13;13:25. doi: 10.1186/1758-2652-13-25. J Int AIDS Soc. 2010. PMID: 20626901 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous